Sun Pharma acquires Chattem Chemicals
This article was originally published in Scrip
Executive Summary
Sun Pharmaceutical Industries, a fully-owned US subsidiary of India's Sun Pharma, has acquired the US-based registered narcotic active pharmaceutical ingredients (API) importer and producer, Chattem Chemicals, from Elcat for an undisclosed sum. The acquisition, Sun's third in the area of controlled substances, is expected to give the company a "better" launch pad in the US for this business.